BCD-089
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BCD-089, covering 2021-02-26 to 2022-05-12. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis [Phase 3]